Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet
Status:
Not yet recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to compare the pharmacokinetics and pharmacodynamics of a new
sublingual formulation of aspirin with that of oral aspirin when administered to healthy
volunteers under fasting conditions. The test product is sublingual aspirin 80 mg
manufactured by Vita Green Health Products Co. Ltd, Hong Kong and the reference product is
oral aspirin 80mg tablet manufactured by Synco (HK) Ltd, Hong Kong.